loadpatents
name:-0.026403903961182
name:-0.013082027435303
name:-0.0046181678771973
Beals; John Michael Patent Filings

Beals; John Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Beals; John Michael.The latest application filed is for "fusion proteins".

Company Profile
3.8.19
  • Beals; John Michael - Solana Beach CA
  • BEALS; John Michael - Indianapolis IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fusion Proteins
App 20220211818 - Baldwin; David Bruce ;   et al.
2022-07-07
Pharmaceutical Combinations Comprising Insulin And At Least An Agent Selected From Meloxicam, Bromfenac Sodium, Acetylsalicylic Acid, Salicyclic Acid And Paracetamol
App 20220175891 - BEALS; John Michael ;   et al.
2022-06-09
Fusion proteins and methods of use
Grant 11,253,574 - Baldwin , et al. February 22, 2
2022-02-22
Fusion Proteins
App 20200390865 - Baldwin; David Bruce ;   et al.
2020-12-17
Pharmaceutical Combinations Comprising Insulin And At Least An Agent Selected From Meloxicam, Bromfenac Sodium, Acetylsalicylic
App 20200261545 - BEALS; John Michael ;   et al.
2020-08-20
Fusion proteins
Grant 10,709,766 - Baldwin , et al.
2020-07-14
Blood glucose lowering compound
Grant 10,035,839 - Baldwin , et al. July 31, 2
2018-07-31
Fusion Proteins
App 20180177851 - Baldwin; David Bruce ;   et al.
2018-06-28
Fusion proteins
Grant 9,855,318 - Baldwin , et al. January 2, 2
2018-01-02
Blood Glucose Lowering Compound
App 20170240614 - BALDWIN; David Bruce ;   et al.
2017-08-24
Fusion Proteins
App 20160324932 - Baldwin; David Bruce ;   et al.
2016-11-10
Treatment for comorbid diabetes with chronic kidney disease
Grant 9,259,479 - Sinha , et al. February 16, 2
2016-02-16
Pegylated Insulin Lispro Compounds
App 20150297681 - Beals; John Michael ;   et al.
2015-10-22
PEGylated insulin lispro compounds
Grant 9,050,371 - Beals , et al. June 9, 2
2015-06-09
Treatment For Comorbid Diabetes With Chronic Kidney Disease
App 20150111819 - Sinha; Vikram Paritosh ;   et al.
2015-04-23
Pegylated Insulin Lispro Compounds
App 20110105392 - Beals; John Michael ;   et al.
2011-05-05
Pegylated Insulin Lispro Compounds
App 20090312236 - Beals; John Michael ;   et al.
2009-12-17
Muteins Of Fibroblast Growth Factor 21
App 20090118190 - Beals; John Michael ;   et al.
2009-05-07
Muteins of fibroblast growth factor 21
Grant 7,491,697 - Beals , et al. February 17, 2
2009-02-17
Heterologous G-Csf Fusion Proteins
App 20080108560 - Beals; John Michael ;   et al.
2008-05-08
Muteins of fibroblast growth factor 21
App 20070142278 - Beals; John Michael ;   et al.
2007-06-21
Erythropoietic compounds
App 20070100133 - Beals; John Michael ;   et al.
2007-05-03
Anti-interleukin-1 beta analogs
App 20050070692 - Beals, John Michael ;   et al.
2005-03-31
Insulin molecule having protracted time action
App 20050014679 - Beals, John Michael ;   et al.
2005-01-20
Hyperglycosylated polypeptides
App 20040254351 - Beals, John Michael ;   et al.
2004-12-16
Treating musculoskeletal disorders using lp85 and analogs thereof
App 20030100502 - Beals, John Michael ;   et al.
2003-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed